DNA identification technology: a powerful tool for the quality control of Chinese medicinal drugs
Article Sidebar
Main Article Content
Abstract
DNA identification technology has been widely utilized in clinical diagnosis of pathogenic microorganisms and genetic diseases. During the past ten years, it has also been incorporated into the Chinese medicinal drugs industry to aid in the authentication of Chinese materia medica (CMM) and raw materials in Chinese patent medicines (CPM). This paper presents an overview of the history behind the development of DNA testing methods for Chinese medicinal drugs, as well as our research team's investigations into authentication of CMM, raw material authentication in CPM, quantitative analysis of Chinese medicinal drugs through DNA quantification, and optimization of DNA testing methods for Chinese medicinal drugs. We also look forward to communicating and collaborating with more institutions to further contribute to the quality control of Chinese medicinal drugs.
Article Details
References
Niu SY, Fan LL. Apple peel system plate Isatidis Radix as usual to muddle through [Internet]. 2011 [cited 2023 Apr 14]. Available from: http://news.qm120.com/s52q/ 2011052531428.htm (in Chinese)
Cheng XL. Research and development of key technology for quality control of glue crude drugs [dissertation]. Beijing: Beijing university of Chinese Medicine; 2014. (in Chinese)
Li M, Au KY, Lam H, Cheng L, But PPH, Shaw PC. Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs. Food Chem. 2014;147:332-9.
Chen R, Dong J, Cui X, Wang W, Yasmeen A, Deng Y, et al. DNA based identification of medicinal materials in Chinese patent medicines. Sci Rep. 2012;2(2):958.
Yuan Y, Deng Y, Wang J, Chen R. A rapid site-specific PCR based one-tube authentication method for saffron in crude drugs and processed herbal medicines. Electrophoresis. 2019;40(8):1251-3.
Yin XM, Gao C, Chen R, Li J, Jiang GH, Tang Z, et al. From electrophoresis detection to visual Judgment: new application of SYBR green I in the authentication of the traditional medicine Rhizoma Paridis. Int J Agric Biol. 2019;22(5):1217-22.
Yin HX, Zhang KY, Ren ZX, Zhao JW, Gao C, Chen R. Paris polyphylla var. yunnanensis genotype classification and fluorescence visual identification. Agron J. 2021;114(4):1971-80.
Chen R, Ding S, Wei YH, Yu JW, Xu RC, Luo X, et al. Ultrafast identification of Pinelliae Rhizoma using colorimetric direct-VPCR. 3 Biotech. 2021;11(12):493.
Wei YH, Ding S, Chen GY, Dong J, Du F, Huang X, et al. Real-time fluorescence and colorimetric identification of Bulbus Fritillariae using recombinase assisted loop-mediated isothermal DNA amplification (RALA). Front Plant Sci. 2022;28(13):948879.
Chen R, Wang J, Yuan Y, Deng Y, Lai X, Du F, et al. Weigh biomaterials by quantifying species-specific DNA with real-time PCR. Sci Rep. 2017;7(1):4774.
Chen R, Wu CL, Deng Y, Bian JH. DNA identification of Chinese patent medicines: a review. Pharmacy and Clinics of Chinese Materia Medica. 2016;7(2):83-6. (in Chinese)
Zhang WJ, Wei F, Ma SC. Discussions and suggestions of standard method study on traditional Chinese medicine identification with DNA molecular biological techniques. Chinese J Pharm Anal. 2020;40(12):2250-5.
Bartlett JMS, Stirling D. A short history of the polymerase chain reaction. Methods in Mol Biol. 2003;226(1):3-6.
Chen R, Lu X, Li M, Chen GY, Deng Y, Du F, et al. Polymerase chain reaction using "v" shape thermal cycling program. Theranostics. 2019;9(6):1572-9.
Chen R, Yu JW, Xu RC, Tang Z. Development and application of an ultra-fast closed-tube Real-time VPCR detection system for Pinellia pedatisecta. Chinese Traditional and Herbal Drugs. 2021;52(18):5722-8.
